z-logo
open-access-imgOpen Access
Immune Suppression Therapy in Aplastic Anemia Secondary to Atezolizumab in a Patient With Stage IV Non-Small Cell Lung Cancer
Author(s) -
WenHan Cheng,
Eldon Brown,
Matt Gorman,
Timothy Babushok
Publication year - 2020
Publication title -
international journal of medical reviews and case reports
Language(s) - English
Resource type - Journals
ISSN - 2534-9821
DOI - 10.5455/ijmrcr.atezolizumab-non-small-cell-lung-cancer
Subject(s) - atezolizumab , medicine , aplastic anemia , immune system , immune checkpoint , oncology , lung cancer , immunotherapy , cancer , adverse effect , immunology , pembrolizumab , bone marrow

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here